SICKLE CELL ANEMIA TESTING AND SCREENING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Key Takeaways from Analyst

The global sickle cell anemia testing and screening market is expected to witness steady growth over the forecast period driven by rising prevalence of the disease across major geographic regions. Developing countries in Asia Pacific and Africa are likely to dominate market growth due to higher disease burden and government initiatives to screen newborns. Furthermore, growing awareness about early diagnosis and treatment of sickle cell anemia through public-private partnership programs will further aid early detection rates.

However, limited funding for sickle cell disease management especially in low and middle-income nations may negatively impact market revenues. Additional restraint includes lack of skilled healthcare professionals for counseling and testing in remote locations.

Nevertheless, development of advanced rapid screening tests with high sensitivity and specificity coupled with point-of-care testing support near patient screening. This offers opportunities for wider geographical reach in resource poor settings. In addition, personalized medicine approach leveraging big data could help customize treatment plans considering individual patient genotypes.